Analysis of Thermal Decomposition Products of Urine at Prostate Cancer and Benign Prostatic Hyperplasia by Terahertz High-Resolution Gas Spectroscopy

Authors: Vaks, Vladimir, Chernyaeva, Mariya, Atduev, Vagif, Anfertev, Vladimir, Maslennikova, Anna, Rodionov, Mikhail, Domracheva, Elena, Atduev, Kurban

Source: 2024 IEEE 9th All-Russian Microwave Conference (RMC) All-Russian Microwave Conference (RMC), 2024 IEEE 9th. :228-232 Nov, 2024

Relation: 2024 IEEE 9th All-Russian Microwave Conference (RMC)

Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial

Authors: Matsubara, Nobuaki, de Wit, Ronald, Balar, Arjun Vasant, Siefker-Radtke, Arlene O., Zolnierek, Jakub, Csoszi, Tibor, Shin, Sang Joon, Park, Se Hoon, Atduev, Vagif, Gumus, Mahmut, Su, Yu-Li, Karaca, Saziye Burcak, Cutuli, Hernán Javier, Sendur, Mehmet A.N., Shen, Liji, O'Hara, Karen, Okpara, Chinyere E., Franco, Sonia, Moreno, Blanca Homet, Grivas, Petros, Loriot, Yohann

Source: In European Urology March 2024 85(3):229-238

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Authors: Bastick, Patricia, Sewak, Sanjeev, Tran, Ben, Pichler, Martin, Shariat, Shahrokh, Rottey, Sylvie, Schatteman, Peter, Schrijvers, Dirk, Verschaeve, Vincent, Vulsteke, Christof, Barros Leite Ferreira, Luiza Aleixo, de Santana Gomes Andrea Juliana, Pereira, Junior, Joao Antonio, Azevedo, Sergio, Bastos, Diogo, Borges, Giuliano, Dettino, Aldo, Antonio, Pires Luis, Luz, Murilo, Martins, Suelen, Mota, Jose Mauricio, Toledo, Joseane, Eigl, Bernhard, Finch, Daygen, Gingerich, Joel, Dong, Haiying, Huang, Jian, Jin, Jie, Pan, Hongming, Sun, Zhongquan, Tian, Ye, Wan, Ben, Wu, Bin, Xu, Ting, Xue, Wei, Zhou, Fangjian, Barthelemy, Philippe, Borchiellini, Delphine, Calcagno, Fabien, Carnot, Aurelien, Cornillon, Pierre, Delva, Remy, Emambux, Sheik, Houede, Nadine, Laguerre, Brigitte, Lauridant, Géraldine, Loriot, Yohann, Mahammedi, Hakim, Maillet, Denis, Pouessel, Damien, Roubaud, Guilhem, Schlurmann-Constans, Friederike, Tosi, Diego, Zanetta, Sylvie, Banek, Severine, Feyerabend, Susan, Kramer, Mario, Niegisch, Guenther, Nuhn, Philipp, Schnabel, Marco, Wuelfing, Christian, Baka, Sofia, Bamias, Aristotelis, Fountzilas, George, Kalofonos, Harabolos, Karalis, Konstantinos, Kotsakis, Athanasios, Timotheadou, Eleni, Landherr, Laszlo, Mangel, Laszlo, Pe’er, Avivit, Levratovsky, Meital, Basso, Umberto, Battelli, Nicola, Cavo, Alessia, De Giorgi, Ugo, Doni, Laura, Galli, Luca, Gigante, Maria Olga, Guadalupi, Valentina, Maio, Michele, Milesi, Laura, Nolè, Franco, Scagliotti, Giorgio, Tortora, Giampaolo, Fukasawa, Satoshi, Harabayashi, Toru, Kamiya, Naoto, Kawahara, Takashi, Kawakita, Mutsushi, Matsubara, Nobunaki, Matsumoto, Kazumasa, Nishimura, Kazuo, Rikiya, Taoka, Shimizu, Nobuaki, Tagaki, Toshio, Kang, Taek Won, Kim, Jwa Hoon, Kim, SeHyun, Lee, Hyo Jin, Lee, Yun-Gyoo, Rha, Sun Young, Seo, Ho Kyung, Los, Maartje, Zurawski, Bogdan, Cortes, Paulo, Faustino, Catia, Vau, Nuno Sineiro, da Luz, Ricardo, Atduev, Vagif, Kirtbaya, Dmitry, Kopyltsov, Evgeny, Lykov, Aleksandr, Marat, Urmantsev, Orlov, Sergey, Penkov, Konstantin, Pirmagomedov, Albert, Semenov, Andrey, Varlamov, Sergey, Anguera, Georgia, Domenech, Montserrat, Girones, Regina, Gonzalez del Alba, Aranzazu, Milagro, Nuria Lainez, Luque, Raquel, Ortega, Esther Martínez, Mellado, Begoña, Méndez Vidal, María Jose, Fernandez, Esteban Nogales, Valderrama, Begoña Perez, Marín, Alvaro Pinto, Santander, Carmen, Huang, Yi-Hsiu, Su, Wen-Pin, Wu, Hung-Chan, Wu, WenJeng, Yu, Kai-Jie, Bilici, Ahmet, Goker, Erdem, Gumus, Mahmut, Karaoglu, Aziz, Kefeli, Umut, Köse, Fatih, Ozguroglu, Mustafa, Tural, Deniz, Turk, Haci, Yalcin, Suayib, Bondarenko, Igor, Khareba, Gennadii, Kidik, Yana, Lychkovskyy, Oleksandr, Sakalo, Valerii, Shevnia, Serghii, Stakhovskyy, Eduard, Bahl, Amit, Crabb, Simon, Powles, Thomas, Sankey, Peter, Sarwar, Mohammad, Benedetto, Pasquale, Burgess, Earle, Dawson, Nancy, Doshi, Gurjyot, Fleming, Mark, Maly, Joseph, Parikh, Mamta, Waterhouse, David, Siefker-Radtke, A.O., Matsubara, N., Park, S.H., Huddart, R.A., Burgess, E.F., Özgüroğlu, M., Valderrama, B.P., Laguerre, B., Basso, U., Triantos, S., Akapame, S., Kean, Y., Deprince, K., Mukhopadhyay, S., Loriot, Y.

Source: In Annals of Oncology January 2024 35(1):107-117

Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial

Authors: Albiges, Laurence, Gurney, Howard, Atduev, Vagif, Suarez, Cristina, Climent, Miguel A, Pook, David, Tomczak, Piotr, Barthelemy, Philippe, Lee, Jae Lyun, Stus, Viktor, Ferguson, Thomas, Wiechno, Pawel, Gokmen, Erhan, Lacombe, Louis, Gedye, Craig, Perini, Rodolfo F, Sharma, Manish, Peng, Xiang, Lee, Chung-Han

Source: Lancet oncology. 24(8):881-891

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194860336.0x000001&indx=1&recIds=ETOCvdc_100194860336.0x000001

Application of High-Resolution Terahertz Gas Spectroscopy for Studying the Composition of Thermal Decomposition Products in Human Urine of Prostate Cancer Patients.

Authors: Vaks, Vladimir^1,2, elena@ipmras.ruvax@ipmras.ru, Domracheva, Elena^1,2, masha@ipmras.ru, Chernyaeva, Maria^1,3, anfertev@ipmras.ru, Anfertev, Vladimir^1,2, misha-as98@mail.ru, Maslennikova, Anna^4,5, atduev7777@gmail.commaslennikova.anna@gmail.com, Atduev, Vagif^6,7, atduev@mail.ru, Atduev, Kurban⁵, Rodionov, Mikhail^1,3

Source: Applied Sciences (2076-3417); Mar2024, Vol. 14 Issue 5, p1955, 11p

Additional efficacy and safety outcomes and an exploratory analysis of the impact of pathological complete response (pCR) on long-term outcomes from NIAGARA.

Authors: Galsky, Matthew D., Van Der Heijden, Michiel Simon, Catto, James W.F., Al-Ahmadie, Hikmat, Meeks, Joshua J, Nishiyama, Hiroyuki, Drakaki, Alexandra, Vu, Toan Quang, Antonuzzo, Lorenzo, Atduev, Vagif, Kann, Ariel Galapo, Kim, Tae-Hwan, Font Pous, Albert, Chang, Chao-Hsiang, De Wit, Ronald, Wojtukiewicz, Marek Z., Xin, Wenjing, Donegan, Sarah E., Hois, Stephan, Powles, Thomas

Source: Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, p659-659, 242p

Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum‐containing chemotherapy: Post hoc analysis of KEYNOTE‐052 and LEAP‐011.

Authors: O'Donnell, Peter H., Loriot, Yohann, Csoszi, Tibor, Matsubara, Nobuaki, Shin, Sang Joon, Park, Se Hoon, Atduev, Vagif, Gumus, Mahmut, Karaca, Saziye Burcak, Grivas, Petros, de Wit, Ronald, Castellano, Daniel E., Powles, Thomas, Vuky, Jacqueline, Zhao, Yujie, O'Hara, Karen, Okpara, Chinyere E., Franco, Sonia, Homet Moreno, Blanca, Żołnierek, Jakub

Source: Cancer (0008543X); Jan2025, Vol. 131 Issue 1, p1-11, 11p

Subject Terms: TRANSITIONAL cell carcinoma, PATIENT safety, BLADDER cancer, OVERALL survival, KIDNEY diseases

Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial

Authors: Sweeney, Christopher, Bracarda, Sergio, Sternberg, Cora N, Chi, Kim N, Olmos, David, Sandhu, Shahneen, Massard, Christophe, Matsubara, Nobuaki, Alekseev, Boris, Parnis, Francis, Atduev, Vagif, Buchschacher, Gary L, Jr, Gafanov, Rustem, Corrales, Luis, Borre, Michael, Stroyakovskiy, Daniil, Alves, Gustavo Vasconcelos, Bournakis, Evangelos, Puente, Javier, Harle-Yge, Marie-Laurence, Gallo, Jorge, Chen, Geng, Hanover, Justin, Wongchenko, Matthew J, Garcia, Josep, de Bono, Johann S ^*

Source: In The Lancet 10-16 July 2021 398(10295):131-142

First-line pembrolizumab plus lenvatinib for non–clear cell renal carcinomas (nccRCC): Extended follow-up of the phase 2 KEYNOTE-B61 study.

Authors: Voss, Martin H, Gurney, Howard, Atduev, Vagif, Suárez, Cristina, Climent, Miguel Ángel, Pook, David William, Tomczak, Piotr, Barthelemy, Philippe, Lee, Jae-Lyun, Nalbandian, Taron, Stus, Viktor, Ferguson, Thomas, Wiechno, Pawel, Gokmen, Erhan, Lacombe, Louis, Gedye, Craig, Burgents, Joseph E., Sharma, Manish, Cornell, Jerry, Albiges, Laurence

Source: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p2-2, 5p

First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.

Authors: Loriot, Yohann, Grivas, Petros, De Wit, Ronald, Balar, Arjun Vasant, Siefker-Radtke, Arlene O., Zolnierek, Jakub, Csoszi, Tibor, Shin, Sang Joon, Park, Se Hoon, Atduev, Vagif, Gumus, Mahmut, Su, Yu-Li, Karaca, Saziye Burcak, Cutuli, Hernan, Sendur, Mehmet Nahit, Jia, Calvin, O'Hara, Karen, Franco, Sonia, Matsubara, Nobuaki

Source: Journal of clinical oncology. 40(6 suppl):432-432

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152993413.0x000001&indx=1&recIds=ETOCvdc_100152993413.0x000001

ADAM: A multicenter, non-interventional, prospective cohort study for determination of prevalence of homologous recombination repair genes mutations (HRRm) in metastatic castrate-resistant prostate cancer (mCRPC)—Interim analysis.

Authors: Alexeev, Boris, Lyubchenko, Liudmila, Gordiev, Marat, Filipenko, Maxim, Anzhiganova, Yulia, Sultanbaev, Alexander, Bystrov, Alexander, Orlov, Alexander, Gopp, Galina, Kopyltsov, Evgeny, Lykov, Alexander, Atduev, Vagif, Alekseeva, Galina, Mailyan, Ovsep, Semenov, Vladislav, Vedrova, Olga, Perevoschikov, Alexander, Andreev, Sergei, Evgenia, Logacheva

Source: Journal of clinical oncology. 40(6 suppl):169-169

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152982359.0x000001&indx=1&recIds=ETOCvdc_100152982359.0x000001

Advanced enteral therapy in acute pancreatitis: Is there a room for immunonutrition? A meta-analysis

Authors: Petrov, Maxim S., Atduev, Vagif A., Zagainov, Vladimir E.

Source: In International Journal of Surgery 2008 6(2):119-124

First-line lenvatinib + pembrolizumab treatment across non-clear cell renal cell carcinomas: Results of the phase 2 KEYNOTE-B61 study.

Authors: Lee, Chung-Han, Gurney, Howard, Atduev, Vagif, Suárez, Cristina, Climent Duran, Miguel A, Pook, David William, Tomczak, Piotr, Barthelemy, Philippe, Lee, Jae-Lyun, Nalbandian, Taron, Stus, Viktor, Ferguson, Thomas, Wiechno, Pawel, Gokmen, Erhan, Lacombe, Louis, Gedye, Craig, Burgents, Joseph, Sharma, Manish, Peng, Xiang, Albiges, Laurence

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p4518-4518, 1p